استعمال النيفيدبين في تثبيط المخاض الباكر- التدبير والآثار الجانبية
Abstract
أجريت الدراسة على عينة عشوائية مكونة من (100) حالة من المريضات الحوامل المقبولات بقصة مخاض باكر في قسم التوليد وأمراض النساء في مشفى الأسد الجامعي- اللاذقية خلال الفترة الممتدة من نيسان 2012حتى نيسان 2013.
تمت دراسة فعاليّة استخدام النيفيدبين في تثبيط المخاض الباكر ودراسة الآثار الجانبية خلال المعالجة و دراسة التكلفة المادية لاستعمال النيفيدبين مقارنة مع التكلفة المادية لاستعمال حالاّت المخاض الأخرى .
بلغت نسبة نجاح النيفيدبين في تثبيط المخاض بطريقة 60مغ خلال 24ساعة الأولى من المعالجة (78.5%) بينما كانت نسبة النجاح (81.1%) بطريقة 90مغ لنفس المدة السابقة .
بلغت نسبة الآثار الجانبية الناجمة عن التطبيق (19.7%) أكثرها تواردا"الصداع بنسبة(50%) من مجمل الآثار الجانبية .
كما تبيّن أن تطبيق النيفيدبين الفموي في تثبيط المخاض الباكر هو أقل تكلفة مادية من استعمال السالبوتامول الوريدي المستخدم لتثبيط المخاض في مشفى الأسد الجامعي .
A Study was conductedon a random sample of (100) cases of pregnancies with preterm labour admitted to Al-Assad University Hospital, Obstetrics and Gynecology section, Lattakiaduring the period April 2012 until April 2013
The efficiency of using nifedipine for inhibiting pre-term labour was studied together with the side effects duringtreatment, and the cost of using nifedipine comparable to using another tocolysis.
The percentage of success in using nifedipine for inhibiting preterm labourby 60m.g method during the first 24h was (78.5%) while it was (81.1%) by 90m.g method for the same period.
The percentageof side effects was (19.7%), of whichheadaches were the most recurrent (50%).
Using oral nifedipine costs less than using intravenousSalbutamolusedtoinhibit preterm labour at Al-Assad University Hospital.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.